Northwest Biotherapeutics: From An Ugly Duckling Bulletin Board Company To A Promising Nasdaq Listing
Read the rest of this article on Healthcare Sector and Stocks Analysis from Seeking Alpha
Related Videos
-
A Rare Time for Wide-Moat Stocks ?StockInvestor editor Paul Larson details recent changes to Morningstar's Wide Moat Focus Index, noting how the rally in wide-moat names could have them more fairly priced than lower-quality stocks .
-
Larson's Strategies for Excess ReturnsStockInvestor editor Paul Larson discusses the importance of investing in companies that can compound their intrinsic values, buying on the cheap, avoiding stop-loss orders, and more.
-
Don't Play Games With Your WithdrawalsOverspending and impatient selling are two moves that can prematurely drain retirees' portfolio income, warns financial columnist Gail MarksJarvis, who offers strategies to avoid these pitfalls.
-
Stocks Attractive on a Relative, But Not Absolute, BasisInvestors should keep their expectations in check with few asset classes looking particularly attractive and complacency in the marketplace, says Allocation Fund Manager of the Year David Giroux of T. Rowe Price Capital Appreciation.